Enanta Pharmaceuticals
ENTA
#7720
Rank
NZ$0.62 B
Marketcap
NZ$21.63
Share price
1.83%
Change (1 day)
136.38%
Change (1 year)

Enanta Pharmaceuticals (ENTA) Fails to deliver data

Key failure to deliver metrics for Enanta Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Enanta Pharmaceuticals (ENTA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Enanta Pharmaceuticals (ENTA) - since 2013

Volume in USD (price x number of shares), data since 2013

Enanta Pharmaceuticals (ENTA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025NZ$1.05 M-0.21%
2024NZ$1.05 M-33.48%
2023NZ$1.58 M-69.53%
2022NZ$5.19 M37.3%
2021NZ$3.78 M22.27%
2020NZ$3.09 M-14.77%
2019NZ$3.63 M-54.06%
2018NZ$7.9 M134.04%
2017NZ$3.37 M-70.94%
2016NZ$11.63 M-27.35%
2015NZ$16 M21.11%
2014NZ$13.21 M124.82%
2013NZ$5.87 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
AbbVie
ABBV
NZ$37.45 MNZ$88 M๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$32.98 MNZ$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$37.57 MNZ$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$36.84 MNZ$0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$29.11 MNZ$80.36 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$73.82 MNZ$0.13 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland